Skip to Content
Search All Programs & Services
Search by Name, Speciality, Program, or Research
Make a Donation
Make an Appointment
Ask a Question
Refer a Patient
Providers > Physicians > Nathan Rabinovitch
Dr. Rabinovitch’s current research focuses on the role of environmental triggers and biomarkers of susceptibility in asthma. These spotlight the effects of ambient air pollution, environmental tobacco smoke and bioaerosols on asthma severity and identifies biomarkers which can be used to individualize medical therapy in asthma.
American Board of Allergy and Immunology
N. Rabinovitch, M. Strand, K. Stuhlman, E.W. Gelfand. Exposure to Tobacco Smoke Increases LTE4-Related Albuterol Usage and Response to Montelukast. 2008 Journal of Allergy and Clinical Immunology 2008:121: 1365-1371.
N. Rabinovitch. Urinary Leukotriene E4. Immunology and Allergy Clinics of North America 2007; 27(4): 651-664.
N. Rabinovitch, L. Zhang, E.W. Gelfand. Urine LTE4 Levels are Associated with Decreased PFTs in Children with Persistent Airway Obstruction. Journal of Allergy and Clinical Immunology 2006; 118: 635-40.
N. Rabinovitch, M. Strand, E.W. Gelfand. Particulate Levels are Associated with Early Asthma Worsening in Children with Persistent Disease. American Journal of Respiratory and Critical Care Medicine 2006; 173: 1098-1105.
N. Rabinovitch, A.H. Liu, L. Zhang, C.E. Rodes, K. Foard, S.J. Dutton, J.R. Murphy, E.W. Gelfand. Importance of the Personal Endotoxin Cloud in School-Age Children with Asthma. Journal of Allergy and Clinical Immunology 2005; 116: 1053-1057.
Link to Faculty Publications
Link to PubMed for more papers
2007-2008: Best Doctors in America: Allergy/Immunology
Associate Professor of Pediatrics
1400 Jackson St Denver, CO 80206 1.877.225.5654 Network of Locations Contact Us
© 2014 National Jewish Health Policies & Guidelines | My National Jewish Health